AcedrA BioPharmaceuticals
Quick facts
- Years trading
- 9 years (since 2017)
- Group size
- 1+
- Delivery formats
- In Person, Virtual Instructor-Led Training (VILT), Hybrid / blended, Meta, Virtual - On-demand learning
- Delivers in
- USA (West Coast), USA (East Coast), USA (Other), Asia, Europe, Australasia, India, UK, UAE, Canada
About AcedrA BioPharmaceuticals
Visit WebsiteAcedrA BioPharmaceuticals specializes in providing innovative scientific and business solutions to clinical and commercial-stage companies in the Middle East and North Africa. Operating since 2017, they focus on addressing unmet medical and commercial needs, particularly in rare and ultra-rare diseases. The company leverages a hybrid platform combining distribution and comprehensive service provision to support the clinical and commercial success of partners globally. AcedrA tracks developments in biotechnology, sourcing and distributing specialty pharmaceuticals and medical devices. They are notable for their commitment to making innovation affordable in the MENA region.
- Group size
- 1+
- Daily rate
- £500
- Number of employees
- 1-10
- Years trading
- 9
- Has own premises
- No
- Apprenticeships
- No
- Funded Courses
- No
Send an Enquiry
Tell us what you need and we’ll help you find the right fit
Tick the box below to confirm you’re human, and we’ll carry on.
What happens next:
Trainers
AcedrA BioPharmaceuticals default trainer
9 years experienceAcedrA BioPharmaceuticals specializes in providing innovative scientific and business solutions to clinical and commercial-stage companies in the Middle East and North Africa. Operating since 2017, they focus on addressing unmet medical and commercial needs, particularly in rare and ultra-rare diseases. The company leverages a hybrid platform combining distribution and comprehensive service provision to support the clinical and commercial success of partners globally. AcedrA tracks developments in biotechnology, sourcing and distributing specialty pharmaceuticals and medical devices. They are notable for their commitment to making innovation affordable in the MENA region.
